Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: CRISPR Therapeutics AG, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CRISPR Therapeutics AG June 4, 202698.2%
-
Incyte Corp. June 10, 202598.6%
-
CRISPR Therapeutics AG June 5, 202597.7%
-
Incyte Corp. June 12, 202499.4%
-
CRISPR Therapeutics AG May 30, 202499.4%
-
Incyte Corp. June 14, 202398.6%
-
CRISPR Therapeutics AG June 8, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | Incyte Corp. | Grant or award | +1,642 | — | — |
| Jun 10, 2025 | Incyte Corp. | Grant or award | +2,518 | — | — |
| Jun 12, 2024 | Incyte Corp. | Grant or award | +2,830 | — | — |
| Jun 14, 2023 | Incyte Corp. | Grant or award | +2,505 | — | — |
Questions about Katherine A. High
What boards is Katherine A. High on?
Katherine A. High sits on the boards of CRISPR Therapeutics AG and Incyte Corp.
How long has Katherine A. High served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.